From: Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
Strategy | Classification basis | Method | Principle | Technique | Advanced features | Refs. |
---|---|---|---|---|---|---|
Membrane-based separation | Magnetizing of oxide metal | Micron-sized metal oxide | Phosphate groups of exosomal lipid bilayer membrane can bind especially with particular oxide of metals (e.g., TiO2, ZrO2) | TiO2-based separation | High yield and fast technique | [98] |
Micron-sized magnetic metal oxide | Magnetic TiO2-based separation | High efficiency to uptake urine-derived exosomes and its fast technique | ||||
Microfluidics-based isolation | Physical properties-based microfluidics | Active isolation | External forces affect different physical characteristics of nanoparticles, such as size, electrical parts, and density | Acoustic force | Sufficient isolation efficacy, fast, versatility, and biocompatibility, | |
Centrifugal microfluidics | Low centrifugal force, comparable recovery, and quick | [103] | ||||
Passive isolation | Combined platforms depended on intricate channel makeup or hydrodynamic properties | Pillar-based microfluidics | Samples with a high pixel density | Â | ||
Hydrodynamic-based microfluidics | Less complexity of fabrication and operation, fast, isolation of exosomes directly from entire blood, reproducibility, and portable | [108] | ||||
Immunoaffinity-based microfluidics | Mobile-coated medium | Magnetic beads or other magnetic nanoparticles coated with antibodies, together they have an enormous surface area and greater handling flexibility | Magnetic bead microfluidics | Sufficient separation, separation performed from entire blood | [105] | |
Merged Raman chip microfluidics | Significant targeting, production, and sensitive | [100] | ||||
Stationary-coated medium | Depend primarily on reaction exosomes with antibodies/aptamers fixed on the roof of microchannels | Double-use chip activated with antibodies | Specificity, high flow rate, high separation efficiency | [109] | ||
Antibody-functionalized enhanced lipid membrane microarrays | High grade of susceptibility and sensitivity | [110] |